Transgentas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 137,669 | 141,462 | 41,315 | 0 | 0 | 0 | 17,684 | 41,249 |
| Profit before tax | -1,554 | 7,402 | -393 | -18 | 0 | 0 | 2,697 | 10,036 |
| Net profit | -1,554 | 7,032 | -393 | -18 | 0 | 0 | 2,562 | 9,434 |
| Equity | 11,825 | 20,441 | 20,048 | 20,030 | 20,030 | 20,030 | 17,697 | 27,130 |
| Liabilities | 35,188 | 22,459 | 2,719 | 1,047 | 1,047 | 953 | 11,849 | 0 |
| Non-current assets | 9,013 | 2,893 | 0 | 0 | 0 | 0 | 13,201 | 11,282 |
| Current assets | 38,000 | 40,007 | 22,767 | 21,077 | 0 | 953 | 16,345 | 15,848 |
| Total assets | 47,013 | 42,900 | 22,767 | 21,077 | 0 | 953 | 29,546 | 27,130 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | - | - | 389 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +18.0% | +2.8% | -70.8% | - | - | - | - | +133.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -3.3% | 16.4% | -1.7% | -0.1% | - | 0.0% | 8.7% | 34.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -13.1% | 34.4% | -2.0% | -0.1% | 0.0% | 0.0% | 14.5% | 34.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -1.1% | 5.0% | -1.0% | - | - | - | 14.5% | 22.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -1.1% | 5.2% | -1.0% | - | - | - | 15.3% | 24.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 3.0 | 1.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.7 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 44,650 | 47,154 | 15,890 | - | - | - | 17,684 | 22,500 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Transgentas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-09 | 571.41 |
| 2026-08-26 | 2026-09-02 | 571.41 |
| 2026-08-23 | 2026-08-23 | 571.41 |
| 2026-08-19 | 2026-08-19 | 571.41 |
| 2026-08-16 | 2026-08-17 | 8.35 |
| 2026-07-23 | 2026-08-14 | 8.35 |
| 2026-07-16 | 2026-07-17 | 402.16 |
| 2026-06-16 | 2026-07-08 | 506.76 |
| 2026-05-28 | 2026-06-07 | 446.53 |
| 2026-05-17 | 2026-05-27 | 447.55 |
| 2026-05-07 | 2026-05-14 | 5.15 |
| 2026-05-04 | 2026-05-06 | 9.68 |
| 2026-05-03 | 2026-05-03 | 447.28 |
| 2026-04-28 | 2026-04-29 | 447.28 |
| 2026-04-27 | 2026-04-27 | 447.55 |
| 2026-04-26 | 2026-04-26 | 442.40 |
| 2026-04-23 | 2026-04-25 | 447.55 |
| 2026-04-20 | 2026-04-22 | 442.40 |
| 2026-03-29 | 2026-03-31 | 414.89 |
| 2026-03-17 | 2026-03-27 | 414.89 |
| 2026-02-18 | 2026-03-04 | 442.40 |
| 2026-01-21 | 2026-02-04 | 297.05 |
| 2026-01-16 | 2026-01-20 | 290.27 |
| 2026-01-01 | 2026-01-05 | 378.62 |
| 2025-12-16 | 2025-12-30 | 378.62 |
| 2025-12-04 | 2025-12-09 | 334.02 |
| 2025-11-18 | 2025-12-03 | 395.07 |
| 2025-10-27 | 2025-11-11 | 327.43 |
| 2025-10-26 | 2025-10-26 | 321.24 |
| 2025-10-23 | 2025-10-25 | 327.43 |
| 2025-10-16 | 2025-10-22 | 321.24 |
| 2025-09-26 | 2025-10-08 | 366.57 |
| 2025-09-16 | 2025-09-25 | 368.02 |
| 2025-08-31 | 2025-09-03 | 460.92 |
| 2025-08-19 | 2025-08-29 | 460.92 |
| 2025-07-28 | 2025-08-05 | 320.15 |
| 2025-07-26 | 2025-07-27 | 315.51 |
| 2025-07-24 | 2025-07-25 | 320.15 |
| 2025-07-16 | 2025-07-23 | 315.51 |
| 2025-06-30 | 2025-07-07 | 334.30 |
| 2025-06-17 | 2025-06-29 | 336.54 |
| 2025-05-16 | 2025-05-26 | 240.38 |
| 2025-05-04 | 2025-05-06 | 317.98 |
| 2025-04-30 | 2025-04-30 | 315.51 |
| 2025-04-28 | 2025-04-29 | 317.98 |
| 2025-04-26 | 2025-04-27 | 315.51 |
| 2025-04-24 | 2025-04-25 | 317.98 |
| 2025-04-16 | 2025-04-23 | 315.51 |
| 2025-03-28 | 2025-04-07 | 160.25 |
| 2025-03-18 | 2025-03-27 | 164.07 |
| 2025-03-04 | 2025-03-05 | 91.47 |
| 2025-03-03 | 2025-03-03 | 137.68 |
| 2025-02-28 | 2025-03-02 | 91.47 |
| 2025-02-18 | 2025-02-27 | 137.68 |
| 2025-02-10 | 2025-02-10 | 236.36 |
| 2025-01-22 | 2025-01-29 | 236.36 |
| 2025-01-16 | 2025-01-21 | 232.77 |
| 2025-01-02 | 2025-01-15 | 67.35 |
| 2024-12-22 | 2024-12-31 | 67.35 |
| 2024-12-17 | 2024-12-20 | 67.35 |
| 2024-11-18 | 2024-12-09 | 126.89 |
| 2024-10-24 | 2024-11-12 | 256.01 |
| 2024-10-18 | 2024-10-23 | 254.12 |
| 2024-10-16 | 2024-10-17 | 351.40 |
| 2024-09-17 | 2024-10-15 | 223.11 |
Transgentas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-07-01 | 2026-07-07 | 604.4 |
| 2026-06-18 | 2026-06-30 | 602.16 |
| 2026-03-02 | 2026-03-02 | 30.11 |
| 2026-02-27 | 2026-03-01 | 30.09 |
| 2026-02-21 | 2026-02-26 | 30.0 |
| 2025-09-17 | 2025-10-09 | 16.56 |
| 2025-07-16 | 2025-09-16 | 0.88 |
| 2025-07-09 | 2025-07-15 | 0.56 |
| 2025-07-01 | 2025-07-08 | 135.56 |
| 2025-06-19 | 2025-06-30 | 135.08 |
| 2025-01-01 | 2025-01-01 | 292.36 |
| 2024-12-31 | 2024-12-31 | 592.12 |
| 2024-12-30 | 2024-12-30 | 591.64 |
| 2024-12-29 | 2024-12-29 | 300.64 |
| 2024-12-23 | 2024-12-28 | 300.16 |
| 2024-12-19 | 2024-12-22 | 299.92 |
| 2024-12-17 | 2024-12-18 | 299.76 |
| 2024-12-16 | 2024-12-16 | 299.6 |
| 2024-12-03 | 2024-12-15 | 298.48 |
| 2024-11-29 | 2024-12-02 | 298.08 |
| 2024-11-20 | 2024-11-28 | 0.08 |
| 2024-11-17 | 2024-11-19 | 0.72 |
| 2024-10-22 | 2024-11-16 | 37.15 |
| 2024-10-10 | 2024-10-13 | 359.46 |
| 2024-10-01 | 2024-10-09 | 360.91 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Transgentas, UAB, a Private Limited Liability Company (code 304223879), operates in logistics service activities. In 2025, the company generated €41.2K in revenue, up 133.3% from €17.7K in 2024. Net profit increased from €2.6K in 2024 to €9.4K in 2025, lifting the profit margin from 14.5% to 22.9%. This indicates a materially stronger operating year and improved profitability alongside rapid top-line expansion. Over the two-year period, both revenue and profit moved upward, with 2025 clearly outperforming 2024.
The balance sheet remained compact and stable. Total assets stood at €27.1K in 2025, equal to equity, and compared with €29.5K in 2024. In 2024, liabilities amounted to €11.8K, while the latest year shows a fully equity-funded position in the reported figures. The company’s asset turnover was 1.52x in 2025, and ROE and ROA were both 34.8%, reflecting efficient use of its asset base and capital in a small-scale business context. Revenue per employee was €41.2K and profit per employee was €9.4K.
The balance sheet remained compact and stable. Total assets stood at €27.1K in 2025, equal to equity, and compared with €29.5K in 2024. In 2024, liabilities amounted to €11.8K, while the latest year shows a fully equity-funded position in the reported figures. The company’s asset turnover was 1.52x in 2025, and ROE and ROA were both 34.8%, reflecting efficient use of its asset base and capital in a small-scale business context. Revenue per employee was €41.2K and profit per employee was €9.4K.